Short answer: no, retatrutide is not available as a medicine in Canada. It is not approved by Health Canada, no pharmacy can dispense it, no prescription can be written for it, and no insurer has a code to bill. That is the whole regulatory picture — and it is also why the question of how to get it has such a different answer here than it does for tirzepatide or semaglutide.
Quick Breakdown: Is Retatrutide Available in Canada?
Quick Answer: Retatrutide is not approved and not available through the conventional system — no pharmacy stock, no prescription route, no insurance coverage, and no announced date for any of that changing. What is available today is research-grade retatrutide, supplied as a lyophilized vial for laboratory use, without a prescription, shipped domestically.| Question | Answer | What It Means For You |
|---|---|---|
| Approved in Canada? | No. Not authorised for sale as a medicine. | No pharmacy can dispense it, at any price. |
| Prescription? | Not possible — there is nothing to prescribe. | A clinic visit will not get you a vial. |
| Insurance? | No benefit code exists. | Nothing to submit, nothing to wait on. |
| When might that change? | No approval date has been announced. | Approval timelines in this class run in years, not months. |
| Available at all? | Yes — as a research material. | $50 for 5 mg to $130 for 30 mg, dispatched in 24–48 hours. |
Why It Is Not Available as a Medicine
Retatrutide is an investigational triple agonist acting on GIP, GLP-1 and glucagon receptors. "Investigational" has a specific meaning: it is still in clinical trials, and no regulator has authorised it for sale. Until that happens, there is no brand product, no pharmacy distribution, no prescription pathway and no insurance coverage — for anyone, at any stage of the trial programme.
This is not a Canadian quirk. The same is true in the United States, the UK and the EU. There is no country where you can walk into a pharmacy today and buy retatrutide, and no supplier claiming otherwise is describing an approved product.
If you want the mechanism and the trial evidence behind the compound, that is covered in the retatrutide guide.
When Will It Be Approved?
No date has been announced, and anyone quoting one is guessing. What can be said honestly is that drugs in this class have moved through large Phase 3 programmes — the TRIUMPH and TRANSCEND trials — and approval decisions typically follow the completion and submission of those datasets. That process is measured in years, not months, and it is not something you can queue for in the meantime.
Which is the practical point: if you are waiting for the pharmacy version, you are not waiting on a waitlist. You are waiting on a regulatory process with no published finish line.
How People Are Getting It Now
The available route is research-grade lyophilized retatrutide: the same molecule, supplied as a powder for laboratory use, priced per milligram, sold without a prescription because it is not sold as a medicine. It is not an approved drug and it is not marketed as a treatment — it is a research material, which is precisely why it can be supplied at all.
What that means in practice:
- No gatekeeper. No appointment, no criteria to meet, no insurer's decision, no pharmacy stock check.
- Choice of strength. 5, 10, 20 and 30 mg vials, priced so the per-milligram cost falls as the vial grows.
- Concentration under your control. You set the diluent volume, which sets mg/mL. The arithmetic is in retatrutide dosing.
- Documentation. Each vial carries a batch number that matches the certificate published on the product page.
What It Costs
| Vial Strength | Price | Cost Per Milligram | Best For |
|---|---|---|---|
| 5 mg | $50 | $10.00 / mg | Small trials, first run. |
| 10 mg | $70 | $7.00 / mg | Short protocols. |
| 20 mg | $110 | $5.50 / mg | The middle option. |
| 30 mg | $130 | $4.33 / mg | Lowest per-milligram price. |
Compare that with the alternative, which is not a cheaper pharmacy price but no pharmacy option at all. The full ordering comparison — what the conventional system can and cannot supply — is in where to buy retatrutide in Canada.
What to Check Before You Buy
- Batch number on the vial matching a certificate published where you bought it. Ours is on the product page.
- Research-use-only labelling. No dosing advice, no therapeutic claims — a supplier promising outcomes is not selling a research chemical.
- Fast domestic dispatch. Stock held in Canada, shipped and tracked within 24–48 hours.
- Per-milligram pricing published. If a supplier only quotes a monthly figure, you cannot compare it to anything.
For the full jurisdictional picture across the US, Canada, the UK and the EU, including the Health Canada file accepted in March 2026, see our approval tracker.
Frequently Asked Questions
Is retatrutide available in Canada?
Not as a medicine. It is unapproved, so there is no pharmacy route and no prescription. It is available as a research-grade material from domestic research suppliers.
Can I get a prescription for retatrutide?
No. A prescription requires an approved drug. Until Health Canada authorises retatrutide, there is nothing for a prescriber to write.
When will retatrutide be available in Canada?
No date has been announced. Approval depends on the Phase 3 programme being completed and reviewed, which is measured in years.
Is it legal to buy in Canada?
Research-grade retatrutide is sold as a laboratory material, not as a medicine. What is regulated is supplying a prescription drug without authorisation — a different activity from supplying a research compound.
How is it different from tirzepatide or semaglutide?
Both of those are approved and available by prescription, which means they have a pharmacy price to compare against. Retatrutide does not — the research route is not an alternative to the pharmacy, it is the only route that exists today.
How fast does it ship?
Packed discreetly and dispatched from British Columbia within 24–48 business hours with tracking. Most Canadian cities arrive in two to four business days.
Retatrutide, Available Now
No approval, no prescription, no insurer — and no waiting for any of that to change. Vials at $50, $70, $110 and $130, with batch numbers matched to published certificates. View Retatrutide Vials →Related research: retatrutide side effects reported in the TRIUMPH trials; weight-loss and progress-tracking evidence.
Premium Collection
Explore selected research products.
✓ COA
✓ COA
Somatropin Human Growth Hormone (HGH) 10-Vial Kit
✓ COA
Free resource
New to peptide research?
The free 51-page guide covers 12 compound profiles, reconstitution math, COA reading and storage — without the hype.
Get the free guide →Or start with the 2-page checklist